FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077776988> ?p ?o ?g. }

• W2077776988 endingPage "460" @default.
• W2077776988 startingPage "453" @default.
• W2077776988 abstract "1. Collagenases are thought to play a major role in the pathology of gas gangrene caused by Clostridium histolyticum, because they can destroy the connective tissue barriers. We investigated possible mediators involved in the oedema formation and plasma protein extravasation which follow the injection of a collagenase (EC 3.4.24.3) from Clostridium histolyticum into one hind paw of anaesthetized rats. 2. The magnitude of the oedema following a subplantar injection was dependent on the dose of collagenase (30, 100 and 300 micrograms) injected. It reached its maximum within 30 min and remained unchanged for at least 5 h. Plasma protein extravasation into the paw was most pronounced within 20 min of the injection. Heat-inactivated collagenase was ineffective. 3. The B2 bradykinin (BK) antagonist icatibant (D-Arg-[Hyp3-Thi5-D-Tic7- Oic8] bradykinin, formerly named Hoe-140) reduced oedema formation in a dose-dependent manner with a maximal reduction of around 65% at a dose of 100 nmol kg-1 (s.c.). A significant effect could already be observed at a dose of 10 nmol kg-1. The duration of the effect of icatibant (100 nmol kg-1) was found to be at least 3 h. These results demonstrate the high potency and long duration of action of icatibant. Pretreatment of rats with the bradykinin B1 antagonist, des-Arg9-[Leu8]-BK did not affect collagenase-induced paw oedema. Thus, the observed collagenase-induced effects are mainly mediated by BK through activation of B2 receptors. 4. Pretreatment of adult rats with capsaicin (125 mg kg-1, s.c.) three weeks before the collagenase injection caused a significant attenuation of the paw oedema and of plasma extravasation but was significantly less effective than icatibant (100 nmol kg-1, s.c.). The non-peptide substance P antagonist,CP-96,345 (l0 micromol kg-1, i.v.) significantly reduced collagenase-induced oedema formation to a degree comparable with that seen after capsaicin pretreatment. The inhibition by the substance P antagonist was significantly smaller than that seen after icatibant. The inhibitory effect of icatibant in capsaicin pretreated rats, or of icatibant together with CP-96,345 in untreated rats, was not greater than that oficatibant alone in rats treated with the vehicle for either capsaicin or CP-96,345. CP-96,344(10 micromol kg-1, i.v.), the inactive enantiomer of CP-96,345, did not affect collagenase-induced paw oedema. In capsaicin-pretreated rats, CP-96,345 (10 micromol kg-1, i.v.) did not reduce collagenase-induced paw oedema.The subplantar injection of bradykinin (30 nmol) induced a paw oedema comparable with that induced by collagenase (100 microg). CP-96,345 (10 micromol kg-1, i.v.), but not CP-96,344 (1O micromol kg-1, i.v.),significantly reduced the bradykinin-induced paw oedema. These findings indicate that collagenase leads to the release of bradykinin; bradykinin then stimulates afferent C-fibre terminals and causes the release of substance P and probably also neurokinin A, which augment the oedema-inducing effect of bradykinin.5. Indomethacin or mepyramine plus cimetidine failed to inhibit collagenase-induced paw oedema.Thus, prostaglandins and histamine do not seem to be involved in collagenase-induced paw oedema.6. After subplantar injection of collagenase, the sensitivity scores in a modified formalin-test rapidly increased during the first 10 min. This increase was abolished by pretreatment with icatibant(100 nmol kg-1, s.c.) indicating that the stimulation of nociceptive afferent neurones following injection of collagenase is due to the action of released kinins.7. In conclusion, bradykinin appears to be the main mediator of inflammation induced by a collagenase from Clostridium histolyticum. As well as having direct relevance to a known pathological condition,collagenase-induced paw oedema could prove to be a useful model in inflammation research and in the investigation of bradykinin antagonists. The present results might provide an experimental basis for clinical investigations of the effects of icatibant in infectious diseases where the release of collagenases from bacteria causes rapid spreading of inflammation." @default.
• W2077776988 created "2016-06-24" @default.
• W2077776988 creator A5000171545 @default.
• W2077776988 creator A5060543320 @default.
• W2077776988 creator A5064351361 @default.
• W2077776988 date "1994-06-01" @default.
• W2077776988 modified "2023-10-17" @default.
• W2077776988 title "Mediation by bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum" @default.
• W2077776988 cites W125317216 @default.
• W2077776988 cites W1966966991 @default.
• W2077776988 cites W1974146850 @default.
• W2077776988 cites W1975952670 @default.
• W2077776988 cites W1986244379 @default.
• W2077776988 cites W1993685329 @default.
• W2077776988 cites W1995127912 @default.
• W2077776988 cites W2000312049 @default.
• W2077776988 cites W2008327322 @default.
• W2077776988 cites W2009936187 @default.
• W2077776988 cites W2018197871 @default.
• W2077776988 cites W2021838814 @default.
• W2077776988 cites W2031682264 @default.
• W2077776988 cites W2031706219 @default.
• W2077776988 cites W2039562943 @default.
• W2077776988 cites W2041936147 @default.
• W2077776988 cites W2071505167 @default.
• W2077776988 cites W2086913393 @default.
• W2077776988 cites W2103006293 @default.
• W2077776988 cites W2325713133 @default.
• W2077776988 cites W2326197515 @default.
• W2077776988 cites W2397703054 @default.
• W2077776988 cites W2418849877 @default.
• W2077776988 cites W4206160836 @default.
• W2077776988 cites W4244444868 @default.
• W2077776988 cites W4255162860 @default.
• W2077776988 doi "https://doi.org/10.1111/j.1476-5381.1994.tb13094.x" @default.
• W2077776988 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1910340" @default.
• W2077776988 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7915609" @default.
• W2077776988 hasPublicationYear "1994" @default.
• W2077776988 type Work @default.
• W2077776988 sameAs 2077776988 @default.
• W2077776988 citedByCount "31" @default.
• W2077776988 countsByYear W20777769882014 @default.
• W2077776988 countsByYear W20777769882015 @default.
• W2077776988 countsByYear W20777769882016 @default.
• W2077776988 countsByYear W20777769882019 @default.
• W2077776988 countsByYear W20777769882021 @default.
• W2077776988 countsByYear W20777769882023 @default.
• W2077776988 crossrefType "journal-article" @default.
• W2077776988 hasAuthorship W2077776988A5000171545 @default.
• W2077776988 hasAuthorship W2077776988A5060543320 @default.
• W2077776988 hasAuthorship W2077776988A5064351361 @default.
• W2077776988 hasBestOaLocation W20777769882 @default.
• W2077776988 hasConcept C126322002 @default.
• W2077776988 hasConcept C134018914 @default.
• W2077776988 hasConcept C142724271 @default.
• W2077776988 hasConcept C170493617 @default.
• W2077776988 hasConcept C181199279 @default.
• W2077776988 hasConcept C185592680 @default.
• W2077776988 hasConcept C2776885963 @default.
• W2077776988 hasConcept C2778211319 @default.
• W2077776988 hasConcept C2778394429 @default.
• W2077776988 hasConcept C2779540182 @default.
• W2077776988 hasConcept C2779591629 @default.
• W2077776988 hasConcept C2779851118 @default.
• W2077776988 hasConcept C2780886150 @default.
• W2077776988 hasConcept C55493867 @default.
• W2077776988 hasConcept C71924100 @default.
• W2077776988 hasConcept C98274493 @default.
• W2077776988 hasConceptScore W2077776988C126322002 @default.
• W2077776988 hasConceptScore W2077776988C134018914 @default.
• W2077776988 hasConceptScore W2077776988C142724271 @default.
• W2077776988 hasConceptScore W2077776988C170493617 @default.
• W2077776988 hasConceptScore W2077776988C181199279 @default.
• W2077776988 hasConceptScore W2077776988C185592680 @default.
• W2077776988 hasConceptScore W2077776988C2776885963 @default.
• W2077776988 hasConceptScore W2077776988C2778211319 @default.
• W2077776988 hasConceptScore W2077776988C2778394429 @default.
• W2077776988 hasConceptScore W2077776988C2779540182 @default.
• W2077776988 hasConceptScore W2077776988C2779591629 @default.
• W2077776988 hasConceptScore W2077776988C2779851118 @default.
• W2077776988 hasConceptScore W2077776988C2780886150 @default.
• W2077776988 hasConceptScore W2077776988C55493867 @default.
• W2077776988 hasConceptScore W2077776988C71924100 @default.
• W2077776988 hasConceptScore W2077776988C98274493 @default.
• W2077776988 hasIssue "2" @default.
• W2077776988 hasLocation W20777769881 @default.
• W2077776988 hasLocation W20777769882 @default.
• W2077776988 hasLocation W20777769883 @default.
• W2077776988 hasLocation W20777769884 @default.
• W2077776988 hasOpenAccess W2077776988 @default.
• W2077776988 hasPrimaryLocation W20777769881 @default.
• W2077776988 hasRelatedWork W2019304601 @default.
• W2077776988 hasRelatedWork W2053602800 @default.
• W2077776988 hasRelatedWork W2060886170 @default.
• W2077776988 hasRelatedWork W2064842891 @default.
• W2077776988 hasRelatedWork W2073195994 @default.
• W2077776988 hasRelatedWork W2079064476 @default.
• W2077776988 hasRelatedWork W2142185274 @default.

• next